TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32966683

Group type: EXPERIMENTAL
Intervention: 60 g/d of mixed nuts (nut group)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Usual Western-style diet avoiding consumption of nuts (control group)
Number of subjects: 72
Study: 32210455

Group type: EXPERIMENTAL
Intervention: EMLA cream (1 g, 25 mg lidocaine + 25 mg prilocaine applied 1 hour prior to puncture)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Lidocaine tape (one sheet, 18 mg lidocaine applied 30 minutes prior to puncture)
Number of subjects: 66
Study: 33583033

Group type: EXPERIMENTAL
Intervention: NAFLD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic variants (PNPLA3, TM6SF2, MBOAT7)
Number of subjects: 0
Study: 36210311

Group type: EXPERIMENTAL
Intervention: Latissimus dorsi flap
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Deep inferior epigastric artery perforator flap
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Thoracodorsal flap and implant
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Expander
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (pre-reconstruction)
Number of subjects: 107
Study: 33103585

Group type: EXPERIMENTAL
Intervention: Handwashing educational intervention
Number of subjects: 82
Study: 32213342

Group type: EXPERIMENTAL
Intervention: Subcutaneous daratumumab (1800 mg co-formulated with 2000 U/mL recombinant human hyaluronidase PH20)
Number of subjects: 522

Group type: COMPARATOR
Intervention: Intravenous daratumumab (16 mg/kg)
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Subcutaneous daratumumab
Number of subjects: 522

Group type: COMPARATOR
Intervention: Intravenous daratumumab
Number of subjects: 522
Study: 34700203

Group type: EXPERIMENTAL
Intervention: Combined household-level piped water and sanitation intervention
Number of subjects: 1045

Group type: COMPARATOR
Intervention: Control villages (no intervention)
Number of subjects: 1045
Study: 33320279

Group type: EXPERIMENTAL
Intervention: Classical conditioning
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Observational learning
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sham conditioning
Number of subjects: 58
Study: 32070386

Group type: EXPERIMENTAL
Intervention: Initial treatment planning
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Replanning after study group meeting
Number of subjects: 25

Group type: COMPARATOR
Intervention: Initial planning
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Replanning
Number of subjects: 25
Study: 36399909

Group type: EXPERIMENTAL
Intervention: Induction therapy (six cycles of 5‐fluorouracil, leucovorin [FU/FA], oxaliplatin [FOLFOX] and panitumumab [Pmab])
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Maintenance therapy (FU/FA plus Pmab)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Maintenance therapy (FU/FA alone)
Number of subjects: 248
Study: 35213289

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg, Bisoprolol 5 mg, Hydrochlorothiazide 25 mg, Losartan 50 mg daily (GENRES)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg, Losartan 50 mg daily (LIFE-Fin)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Bisoprolol 5 mg (GENRES)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Four different antihypertensive drugs (general)
Number of subjects: 400
Study: 33439315

Group type: EXPERIMENTAL
Intervention: T2‐FLAIR radiomics signature
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: T1‐CE, T2‐FLAIR, T2WI, DWI radiomics signature
Number of subjects: 52
Study: 35452458

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Low-dose remifentanil (0.25 mcg/kg/min)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High-dose remifentanil (0.5 mcg/kg/min)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Remifentanil (combined dosage)
Number of subjects: 32
Study: 32474993

Group type: EXPERIMENTAL
Intervention: Modified release melatonin
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 32229597

Group type: EXPERIMENTAL
Intervention: Intensive therapy (n = 4,755)
Number of subjects: 9483

Group type: COMPARATOR
Intervention: Standard therapy (n = 4,728)
Number of subjects: 9483
Study: 33582256

Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM)
Number of subjects: 66
Study: 35830845

Group type: EXPERIMENTAL
Intervention: Inverted classroom combined with case presentations (test group)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (only attending pre-clinical training)
Number of subjects: 59
Study: 33559157

Group type: EXPERIMENTAL
Intervention: Psychosocial stressor
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 115
Study: 35733211

Group type: EXPERIMENTAL
Intervention: Implementation support for one of four evidence-based practices
Number of subjects: 33

Group type: COMPARATOR
Intervention: No implementation support for the other evidence-based practices
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Implementation support after 18 months
Number of subjects: 33
Study: 36384484

Group type: EXPERIMENTAL
Intervention: Rapid on-site test (ROST) arm at PLC
Number of subjects: 1128

Group type: EXPERIMENTAL
Intervention: Rapid on-site test (ROST) arm at ACH
Number of subjects: 1128

Group type: COMPARATOR
Intervention: Standard arm at PLC
Number of subjects: 1128

Group type: COMPARATOR
Intervention: Standard arm at ACH
Number of subjects: 1128
Study: 32776202

Group type: EXPERIMENTAL
Intervention: Tiotropium/Olodaterol 5/5 µg
Number of subjects: 9942

Group type: COMPARATOR
Intervention: Tiotropium 5 µg
Number of subjects: 9942
Study: 36165878

Group type: EXPERIMENTAL
Intervention: Open-label placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naloxone (10 mg hidden injection)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline solution (hidden injection)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Natural history control group
Number of subjects: 0
Study: 32946500

Group type: EXPERIMENTAL
Intervention: Performance-based financing (PBF) scheme for malnutrition services
Number of subjects: 6480

Group type: COMPARATOR
Intervention: Control group with simple budget allocation
Number of subjects: 6480
Study: 36302157

Group type: EXPERIMENTAL
Intervention: Cycling exercise with core temperature increased to +2°C TC
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cycling exercise with core temperature increased to +1°C TC
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cycling exercise without heat stress (thermoneutrality)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cycling exercise with heat stress at +1°C TC
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cycling exercise with heat stress at +2°C TC
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cycling exercise with heat stress at +1°C TC and +2°C TC
Number of subjects: 12
Study: 34914568

Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 263

Group type: COMPARATOR
Intervention: Allopurinol
Number of subjects: 263
Study: 33962579

Group type: EXPERIMENTAL
Intervention: PSMA PET/CT prior to definitive radiation therapy (dRT)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Standard dRT
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: PSMA PET/CT
Number of subjects: 312
Study: 32260313

Group type: EXPERIMENTAL
Intervention: Monopolar dielectric radiofrequency (MDR) treatment (8 sessions of 20 minutes each)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sham MDR therapy (8 sessions of 20 minutes each)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 66
Study: 36216314

Group type: EXPERIMENTAL
Intervention: STOP clinic intervention
Number of subjects: 436

Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 436

Group type: COMPARATOR
Intervention: STOP clinic intervention and Routine care (control)
Number of subjects: 436
Study: 33389715

Group type: EXPERIMENTAL
Intervention: motor‐cognitive dual task training (mCdtt)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: motor‐motor dual task training (mMdtt)
Number of subjects: 50
Study: 35726109

Group type: EXPERIMENTAL
Intervention: Ambulant Activity Feedback (AAF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: eMBCT (web-based mindfulness-based cognitive therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psycho-education control group (PE)
Number of subjects: 0
Study: 34762770

Group type: EXPERIMENTAL
Intervention: Dapivirine (DPV) arm
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo (PLB) arm
Number of subjects: 168
Study: 32871616

Group type: EXPERIMENTAL
Intervention: Intravenous iron (IVI)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Oral iron (OI)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Preoperative resolution of anaemia (pooled analysis)
Number of subjects: 110
Study: 35908731

Group type: EXPERIMENTAL
Intervention: Cytisine plus counseling (N = 470)
Number of subjects: 869

Group type: COMPARATOR
Intervention: Counseling alone (N = 399)
Number of subjects: 869
Study: 34504409

Group type: EXPERIMENTAL
Intervention: Grass biochar and inorganic fertilizer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chat biochar
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controlled treatments (no biochar)
Number of subjects: 0
Study: 35332654

Group type: EXPERIMENTAL
Intervention: Liraglutide (≤1.8 mg/day)
Number of subjects: 1184

Group type: EXPERIMENTAL
Intervention: Semaglutide (0.5 or 1.0 mg/week)
Number of subjects: 1184
Study: 36910414

Group type: EXPERIMENTAL
Intervention: Video information in addition to the standard pre‐anaesthetic review
Number of subjects: 37

Group type: COMPARATOR
Intervention: Standard pre‐anaesthetic review
Number of subjects: 37
Study: 34468696

Group type: EXPERIMENTAL
Intervention: Intensive SBP lowering (<120 mm Hg)
Number of subjects: 9361
Study: 33852252

Group type: EXPERIMENTAL
Intervention: Calcipotriene 0.005% and betamethasone dipropionate 0.064% foam (Cal/BD)
Number of subjects: 650
Study: 32277617

Group type: EXPERIMENTAL
Intervention: Bevacizumab combined with nedaplatin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Carboplatin alone (Control)
Number of subjects: 100
Study: 33556409

Group type: EXPERIMENTAL
Intervention: anodal tDCS (a‐tDCS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: sham tDCS
Number of subjects: 12
Study: 32876119

Group type: EXPERIMENTAL
Intervention: Bio‐C Pulpo (n = 36)
Number of subjects: 70

Group type: COMPARATOR
Intervention: MTA Angelus (n = 34)
Number of subjects: 70
Study: 35312188

Group type: EXPERIMENTAL
Intervention: Generalized additive mixed model (GAMM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Linear multilevel treatment‐by‐covariate interaction
Number of subjects: 0
Study: 33480860

Group type: EXPERIMENTAL
Intervention: FitMindKit (12-module psychotherapy intervention)
Number of subjects: 1986

Group type: COMPARATOR
Intervention: HealthWatch (12-module program providing general health information)
Number of subjects: 1986
Study: 32188005

Group type: EXPERIMENTAL
Intervention: Riceberry rice bread (RRB)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Wheat bread (WB)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Hom Mali bread (HMB)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All breads
Number of subjects: 16
Study: 34353070

Group type: EXPERIMENTAL
Intervention: Closed-loop health management (CLHM) system based on an Internet platform
Number of subjects: 102

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 102
Study: 32106837

Group type: EXPERIMENTAL
Intervention: Prophylactic quadrivalent HPV vaccine
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control group (no HPV vaccination)
Number of subjects: 312
Study: 32714385

Group type: EXPERIMENTAL
Intervention: Real stimulation (iTBS on rpSTS)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 32
Study: 36053072

Group type: EXPERIMENTAL
Intervention: Pandemic period (March 1, 2020 to February 28, 2021)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Pre pandemic period (March 1, 2019 to February 29, 2020)
Number of subjects: 429
Study: 33024556

Group type: EXPERIMENTAL
Intervention: Laparoscopic trans-abdominal pre-peritoneal (TAPP) repair using 2 separate meshes
Number of subjects: 180

Group type: COMPARATOR
Intervention: Open pre-peritoneal (PP) single mesh repair
Number of subjects: 180

Group type: COMPARATOR
Intervention: Bilateral Lichtenstein repair
Number of subjects: 180
Study: 35560107

Group type: EXPERIMENTAL
Intervention: i-Dashboard
Number of subjects: 169

Group type: COMPARATOR
Intervention: Established EMR
Number of subjects: 169
Study: 32244044

Group type: EXPERIMENTAL
Intervention: Paced-strength-training (PST)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Self-paced strength-training (SPST)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Isometric strength-training (IST)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 35790915

Group type: EXPERIMENTAL
Intervention: IMA intervention (shared decision-making intervention based on the Theoretical Model of Non-initiation)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 24
Study: 35362891

Group type: EXPERIMENTAL
Intervention: PSMA-PET/CTpost
Number of subjects: 116

Group type: COMPARATOR
Intervention: PSMA-PET/CTpre
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: PSMA-PET/CTpost (≤ 1 week)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: PSMA-PET/CTpost (12 weeks)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: PSMA-PET/CTpost (25 weeks)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: PSMA-PET/CTpost and PSMA-PET/CTpre
Number of subjects: 116
Study: 32758677

Group type: EXPERIMENTAL
Intervention: 100 mcg nebulized fentanyl
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 36120688

Group type: EXPERIMENTAL
Intervention: Early rehabilitation nursing based on Orem's self-care theory
Number of subjects: 60
Study: 33797074

Group type: EXPERIMENTAL
Intervention: Chlorpromazine 12.5 mg
Number of subjects: 66

Group type: COMPARATOR
Intervention: Prochlorperazine 12.5 mg
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Chlorpromazine
Number of subjects: 66

Group type: COMPARATOR
Intervention: Prochlorperazine
Number of subjects: 66
Study: 32179586

Group type: EXPERIMENTAL
Intervention: Global longitudinal LV strain by speckle tracking echocardiography
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Detection of replacement fibrosis by late gadolinium enhancement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T1 mapping techniques
Number of subjects: 0
Study: 35506164

Group type: EXPERIMENTAL
Intervention: MK-1654 (100 mg i.m.)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: MK-1654 (300 mg i.m.)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: MK-1654 (300 mg i.v.)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: MK-1654 (1000 mg i.v.)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: MK-1654
Number of subjects: 44
Study: 33909354

Group type: EXPERIMENTAL
Intervention: Acupuncture for regulating shen and strengthening spleen, applied to acupoints Baihui (GV 20), Yintang (GV 29), Tianshu (ST 25), Shangjuxu (ST 37), and Zusanli (ST 36), treatment given once every 2 days, 3 times a week for 6 weeks.
Number of subjects: 231

Group type: COMPARATOR
Intervention: Pinaverium bromide, 50 mg orally, 3 times daily for 6 weeks.
Number of subjects: 231
Study: 34346566

Group type: EXPERIMENTAL
Intervention: International nursing group
Number of subjects: 38

Group type: COMPARATOR
Intervention: Transcultural nursing group
Number of subjects: 38

Group type: COMPARATOR
Intervention: Complementary and alternative medicine group
Number of subjects: 38
Study: 35773693

Group type: EXPERIMENTAL
Intervention: Xing‐Nao Kai‐Qiao acupuncture therapy plus language training
Number of subjects: 252

Group type: COMPARATOR
Intervention: Sham‐acupoint acupuncture therapy plus language training
Number of subjects: 252
Study: 33595635

Group type: EXPERIMENTAL
Intervention: LIRE intervention (inserting epidemiological information into lumbar spine imaging reports)
Number of subjects: 238886
Study: 36433406

Group type: EXPERIMENTAL
Intervention: Diegetic guidance methods (specific methods not detailed)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brand familiarity
Number of subjects: 0
Study: 34509900

Group type: EXPERIMENTAL
Intervention: Community Integration Scale for Adults with Psychiatric Disorders (CIS‐APP)
Number of subjects: 612
Study: 34820931

Group type: EXPERIMENTAL
Intervention: Grid annotation ablation technique
Number of subjects: 88

Group type: COMPARATOR
Intervention: Point-by-point ablation guided by Ablation Index (AI) annotation
Number of subjects: 88
Study: 33164211

Group type: COMPARATOR
Intervention: Small Number books (1-3)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Large Number books (4-6)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (non-numerical) books
Number of subjects: 100
Study: 34625847

Group type: EXPERIMENTAL
Intervention: 0.1% fluorometholone eyedrops
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.45% ketorolac tromethamine eyedrops
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.1% fluorometholone + 0.45% ketorolac tromethamine eyedrops
Number of subjects: 120

Group type: COMPARATOR
Intervention: No eyedrops (control group)
Number of subjects: 120
Study: 34168210

Group type: EXPERIMENTAL
Intervention: Coarse eggshell (ESC; 3-5 mm)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Fine eggshell (ESF; < 1 mm)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Oyster shell (OS; 3-16 mm)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Cockle shell (CS; 1-4 mm)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Limestone (LS; < 2 mm and 2-4 mm mixed in the ratio of 3:7)
Number of subjects: 450
Study: 32524226

Group type: EXPERIMENTAL
Intervention: IHR (Intermittent Hypoxic Breathing)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: IHT (Intermittent Hypoxic Training)
Number of subjects: 47

Group type: COMPARATOR
Intervention: CON (Control)
Number of subjects: 47
Study: 37516844

Group type: EXPERIMENTAL
Intervention: Family intervention with Brazilian‐adapted Planetary Healthy Diet (PHD), reduced portion sizes, increased physical activity, reduced sedentary behavior, and reduced sodium salt plus anti‐inflammatory herbs.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group receiving a print of the Brazilian dietary guideline.
Number of subjects: 0
Study: 34482657

Group type: EXPERIMENTAL
Intervention: Supportive program (education regarding breast cancer; progressive muscle relaxation; stress management; emotional coping; problem-solving strategies)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Supportive program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no supportive program)
Number of subjects: 60
Study: 33571957

Group type: COMPARATOR
Intervention: N20 (20-minute nap opportunity)
Number of subjects: 9

Group type: COMPARATOR
Intervention: CAF (5 mg·kg‐1 caffeine)
Number of subjects: 9

Group type: COMPARATOR
Intervention: CAF+N (caffeine before N20)
Number of subjects: 9
Study: 32996442

Group type: EXPERIMENTAL
Intervention: Housing First (HF) program with Assertive Community Treatment team support
Number of subjects: 703

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 703
Study: 34962595

Group type: EXPERIMENTAL
Intervention: Algorithm in the time domain
Number of subjects: 13

Group type: COMPARATOR
Intervention: Both algorithms
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: PRBS testing
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Incrementally increasing exercise intensities
Number of subjects: 13
Study: 34068235

Group type: EXPERIMENTAL
Intervention: Intervention (INT) - Action Schools! BC program (16 schools, 747 students)
Number of subjects: 1529

Group type: COMPARATOR
Intervention: Control (UP) - Usual practice (14 schools, 782 students)
Number of subjects: 1529
Study: 33295307

Group type: EXPERIMENTAL
Intervention: Large Jejunal Incision (LJI)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Small Jejunal Incision (SJI)
Number of subjects: 48
Study: 36239367

Group type: COMPARATOR
Intervention: L0% (no load)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L10% (10% of body weight)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L20% (20% of body weight)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Comparison of NL and DL during L10%
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Comparison of NL and DL during L0%
Number of subjects: 12
Study: 33156289

Group type: EXPERIMENTAL
Intervention: Low-Molecular-Weight Heparin (LMWH)
Number of subjects: 20341

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UH)
Number of subjects: 20341
Study: 33423021

Group type: EXPERIMENTAL
Intervention: Group-led creative writing workshop (CWW)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Active control (AC)
Number of subjects: 60
Study: 33449418

Group type: EXPERIMENTAL
Intervention: Assessment plus computer-generated individualized feedback letters at baseline and months 3 and 6
Number of subjects: 1646

Group type: COMPARATOR
Intervention: Assessment only
Number of subjects: 1646
Study: 32761191

Group type: COMPARATOR
Intervention: Ketogenic Diet (KD)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Modified Atkins Diet (MAD)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Low Glycemic Index Therapy Diet (LGIT)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Ketogenic Diet (KD) vs Modified Atkins Diet (MAD)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Ketogenic Diet (KD) vs Low Glycemic Index Therapy Diet (LGIT)
Number of subjects: 158
Study: 35059305

Group type: EXPERIMENTAL
Intervention: Chatbot therapy (n = 41)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Bibliotherapy (n = 42)
Number of subjects: 83
Study: 34637414

Group type: EXPERIMENTAL
Intervention: Mild therapeutic hypothermia (32.0-34.0°C)
Number of subjects: 459

Group type: COMPARATOR
Intervention: Targeted normothermia (36.0-37.0°C)
Number of subjects: 459
Study: 34845002

Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg monthly
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240